A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Coronaviruses are a genetically diverse family of viruses that infect birds and mammals, with most coronavirus strains limited to infecting only certain hosts. Human coronaviruses, for example, cause up to 30 percent of common colds.
In the last 15 years, however, coronaviruses have demonstrated their ability to jump into new species. Zoonotic (animal) coronaviruses have infected humans, causing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe diseases with high mortality rates ranging from 10 percent for SARS to 40 percent for MERS. The MERS-coronavirus continues to cause new infections in the Middle East.
“There’s a real concern that the MERS coronavirus could escape broadly when millions of people visit Saudi Arabia for the Hajj,” said Mark Denison, M.D., Craig-Weaver Professor of Pediatrics and professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.
But to date, there has been no effective antiviral drug for any known coronavirus, Denison noted.
Denison and his team at Vanderbilt have studied the basic biology of coronaviruses for more than 20 years. In an effort to find chemical tools that would allow them to probe viral replication, graduate student Brett Case screened a series of compounds selected and provided by Gilead Sciences.
Case demonstrated that one of the compounds was highly active against coronaviruses in cultured cells. The finding was a surprise, Denison said, because compounds in the same class (nucleoside analogs) have normally failed to inhibit coronavirus replication.
The compound, called GS-5734, is currently in clinical development for treatment of Ebola virus disease.
Denison’s longtime collaborator Ralph Baric, Ph.D., at the University of North Carolina and his team demonstrated that GS-5734 inhibits SARS-coronavirus and MERS-coronavirus replication in multiple in vitro systems, including cultures of primary human airway epithelial cells, which are the cells infected by respiratory coronaviruses.
The researchers also showed that GS-5734 was effective against a circulating human coronavirus, bat coronaviruses, and bat coronaviruses that are considered “prepandemic” because they can infect cultured human cells.
Using a mouse model of SARS, the investigators demonstrated that both prophylactic (before infection) and early therapeutic (soon after infection) administration of GS-5734 reduced viral load in the lungs and improved respiratory functions.
“This compound shows broad activity against a variety of human and animal coronaviruses and represents an exciting potential therapeutic for a family of viruses prone to emergence from animal reservoirs,” Denison said.
Denison and his team at Vanderbilt will continue to use the compound “as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses,” he said.
“This is an exciting example of how pursuing fundamental research to understand the mechanisms of virus replication and pathogenesis can lead to an important compound with therapeutic potential.”
The Latest on: Coronaviruses
- WHO-led coalition needs $31.3 billion to fight COVID-19on June 26, 2020 at 6:05 am
The World Health Organization-led coalition fighting the coronavirus needs $31.3 billion over the next 12 months to develop and roll out tests, treatments and vaccines, it said on Friday.
- Social care workers at increased risk of death from coronavirus, ONS findson June 26, 2020 at 6:04 am
Those in sector in England and Wales are significantly more likely to die from Covid-19 than working-age people as a whole ...
- Americans show rising concerns over coronavirus as cases spike nationwide: pollon June 26, 2020 at 6:02 am
More than 75 percent of Americans are afraid of contracting the coronavirus, a new ABC News/Ipsos poll finds, as ...
- Coronavirus: Milton Keynes Acorn Nursery stays open as 23 test positiveon June 26, 2020 at 5:57 am
A nursery school has been allowed to remain open after 23 staff, pupils and parents tested positive for Covid-19. Acorn Nursery, at the Westcroft Centre in Milton Keynes, said those affected had ...
- Goran Ivanisevic: Novak Djokovic's coach has coronaviruson June 26, 2020 at 5:55 am
Novak Djokovic's coach Goran Ivanisevic is the latest person involved with the world number one's Adria Tour to test positive for coronavirus.
- Gold on course for third weekly gain as coronavirus cases spikeon June 26, 2020 at 5:54 am
Gold prices edged up on Friday en route to a third straight weekly gain, as a spike in coronavirus cases dashed hopes of a quick economic recovery.
- Eye Opener: CDC estimates COVID-19 infections may be 10 times higher than knownon June 26, 2020 at 5:35 am
The CDC estimates that U.S. coronavirus cases may be 10 times higher than reported. Also, a massive cloud of Saharan dust has blanketed the Caribbean and is heading for the U.S. All that and all that ...
- Paris and Eugene Diamond League meetings scrapped due to coronaviruson June 26, 2020 at 5:33 am
This year's Diamond League athletics meetings in Paris and Eugene have been canceled due to the COVID-19 pandemic, organizers said on Friday.
- White House coronavirus task force holds first briefing in nearly 2 monthson June 26, 2020 at 5:27 am
The White House coronavirus task force will hold a news briefing Friday -- its first in nearly two months -- after the United States set a new record for new COVID-19 cases recorded in a single day.
- COVID-19 Cluster Among Migrants Causes Angry Confrontations in Southern Italian Townon June 26, 2020 at 5:06 am
Italy has sent soldiers to restore order in a coastal town near Naples after a coronavirus outbreak at an apartment complex illegally occupied by hundreds of migrant workers caused angry ...
via Google News and Bing News